Is Folate (Methylfolate) Safe with Paroxetine?
Free · No account · based on published sources including NIH ODS, FDA drug labels, and peer-reviewed literature
Due to paroxetine's potent anticholinergic and serotonergic profile, long-term use carries a higher risk of folate-pathway disruption. Supplement with L-methylfolate 7.5–15 mg/day (prescription strength) if poor response to paroxetine is observed, under physician guidance.
Why this interaction occurs
Paroxetine has among the highest protein binding and serotonin reuptake inhibition of all SSRIs, potentially exerting greater influence on one-carbon metabolism pathways dependent on folate. Clinical trials including the DEPRESS study have demonstrated that adjunctive L-methylfolate significantly improved outcomes in patients with MDD showing suboptimal SSRI response, particularly in those with elevated inflammatory markers and low folate status.
Evidence
Evidence level: strong.
Reported safety data
The FDA’s adverse event reporting system (FAERS) has received 53,308 reports mentioning Paroxetine. This reflects reported cases involving the medication in general — not confirmed causation, and not specific to the Paroxetine + supplement combination on this page.
FAERS reports are voluntary and cannot prove that a drug caused an event. Do not use report counts to assess the safety of this specific drug-supplement pair.
Frequently asked questions
Related interactions
All Folate (Methylfolate) interactions → · All Paroxetine interactions →
Already checked this one — check your whole list
Educational only — not medical advice.
Always confirm with your doctor or pharmacist.